Health Care [ 2/12 ] | Health Care Equipment & Supplies [ 36/73 ]
NASDAQ | Common Stock
Sight Sciences, Inc., an ophthalmic medical device company, focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of eye prevalent diseases.
The company operates in two segments, Surgical Glaucoma and Dry Eye.
Its products include OMNI surgical system, an implant-free, handheld, single-use, therapeutic technology that enables ophthalmic surgeons to perform a comprehensive procedure indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma, as well as for the catheterization and transluminal viscodilation of Schlemm's canal and cutting of the trabecular meshwork to reduce intraocular pressure in adult patients with open-angle glaucoma; and SION surgical instrument, a bladeless manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork.
The company also provides TearCare system, a dry eye device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality.
It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States.
The company was incorporated in 2010 and is headquartered in Menlo Park, California.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Aug 7, 25 | -0.23 Increased by +8.00% | -0.26 Increased by +11.54% |
| Apr 30, 25 | -0.28 Increased by +15.15% | -0.28 |
| Mar 5, 25 | -0.23 Decreased by -4.55% | -0.18 Decreased by -30.68% |
| Nov 7, 24 | -0.22 Increased by +18.52% | -0.21 Decreased by -4.76% |
| Aug 1, 24 | -0.25 Increased by +16.67% | -0.30 Increased by +16.67% |
| May 2, 24 | -0.33 Increased by +5.71% | -0.28 Decreased by -17.86% |
| Mar 7, 24 | -0.22 Increased by +37.14% | -0.32 Increased by +31.25% |
| Nov 7, 23 | -0.27 Increased by +41.30% | -0.32 Increased by +15.62% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Jun 30, 25 | 19.56 M Decreased by -8.45% | -11.94 M Increased by +3.15% | Decreased by -61.04% Decreased by -5.79% |
| Mar 31, 25 | 17.51 M Decreased by -9.12% | -14.15 M Increased by +12.98% | Decreased by -80.84% Increased by +4.25% |
| Dec 31, 24 | 19.07 M Increased by +1.72% | -11.85 M Decreased by -10.80% | Decreased by -62.11% Decreased by -8.93% |
| Sep 30, 24 | 20.16 M Increased by +0.74% | -11.07 M Increased by +15.11% | Decreased by -54.90% Increased by +15.73% |
| Jun 30, 24 | 21.37 M Decreased by -8.95% | -12.33 M Increased by +16.44% | Decreased by -57.69% Increased by +8.22% |
| Mar 31, 24 | 19.27 M Increased by +2.34% | -16.27 M Increased by +4.69% | Decreased by -84.43% Increased by +6.87% |
| Dec 31, 23 | 18.75 M Decreased by -8.72% | -10.69 M Increased by +36.77% | Decreased by -57.02% Increased by +30.72% |
| Sep 30, 23 | 20.01 M Increased by +7.13% | -13.04 M Increased by +41.36% | Decreased by -65.15% Increased by +45.26% |